|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:136-140
© 2005 The American Association for Thoracic Surgery
General Thoracic Surgery |
Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Le Plessis Robinson, France
Received for publication June 9, 2004; revisions received September 3, 2004; accepted for publication September 22, 2004. * Address for reprints: Elie Fadel, MD, PhD, Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, 133 Avenue de la Résistance, 92350 Le Plessis Robinson, France (Email: fadel{at}ccml.com).
BACKGROUND: Management of solitary adrenal metastasis from non-small cell lung cancer is still debated. Although classically considered incurable, various reports with small numbers of patients have shown that surgical treatment might improve long-term survival. The aim of this study was to review our experience and to identify factors that could affect survival.
METHODS: From January 1989 through April 2003, 23 patients underwent complete resection of an isolated adrenal metastasis after surgical treatment of non-small cell lung cancer. There were 19 men and 4 women, with a mean age of 54 ± 10 years. The diagnosis of adrenal metastasis was synchronous with the diagnosis of non-small cell lung cancer in 6 patients and metachronous in 17 patients. The median disease-free interval for patients with metachronous metastasis was 12.5 months (range, 4.560.1 months).
RESULTS: The overall 5-year survival was 23.3%. Univariate and multivariate analysis demonstrated that a disease-free interval of greater than 6 months was an independent and significant predictor of increased survival in patients after adrenalectomy. All patients with a disease-free interval of less than 6 months died within 2 years of the operation. The 5-year survival was 38% after resection of an isolated adrenal metastasis that occurred more than 6 months after lung resection. Adjuvant therapy and pathologic staging of non-small cell lung cancer did not affect survival.
CONCLUSIONS: Surgical resection of metachronous isolated adrenal metastasis with a disease-free interval of greater than 6 months can provide long-term survival in patients previously undergoing complete resection of the primary non-small cell lung cancer.
This article has been cited by other articles:
![]() |
T. Tanvetyanon, L. A. Robinson, M. J. Schell, V. E. Strong, R. Kapoor, D. G. Coit, and G. Bepler Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non-Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis J. Clin. Oncol., March 1, 2008; 26(7): 1142 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Shen, B. F. Meyers, J. M. Larner, and D. R. Jones Special Treatment Issues in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 290S - 305S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hunt, S. C. Rankin, and L. Lang-Lazdunski Combined lung resection and transdiaphragmatic adrenalectomy in patients with non-small cell lung cancer and homolateral solitary adrenal metastasis. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 194 - 195. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |